Putative function of TAP63α during endochondral bone formation

Gene

Volumn 495, Issue 2, 2012, Pages 95-103

  Li, Feifei ^a,b   Lu, Yaojuan ^a   Ding, Ming ^a   Wu, Guojun ^c   Sinha, Satrajit ^d   Wang, Siying ^b   Zheng, Qiping ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b ANHUI MEDICAL UNIVERSITY   (China)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY AT BUFFALO   (United States)

Author keywords

Col10a1; Endochondral bone formation; Hypertrophic chondrocytes; P63; Transgenic mice

Indexed keywords

HYPERTROPHIC CHONDROCYTE SPECIFIC TYPE X COLLAGEN PROTEIN; PROTEIN; PROTEIN BCL 2; PROTEIN P63; TAP63 ALPHA PROTEIN; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; CARTILAGE CELL; CONTROLLED STUDY; ENCHONDRAL OSSIFICATION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSSIFICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; WILD TYPE;

ANIMALS; BONE MATRIX; CELLS, CULTURED; CHONDROCYTES; COLLAGEN TYPE X; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HYPEROSTOSIS; MICE; MICE, TRANSGENIC; NUCLEAR PROTEINS; OSTEOGENESIS; PHOSPHOPROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SOX9 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

MUS; MUS MUSCULUS;

EID: 84862778169     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2011.12.057     Document Type: Article

References (38)

1. Bonewald L.F., Harris S.E., Rosser J., Dallas M.R., Dallas S.L., Camacho N.P., Boyan B., Boskey A. von Kossa staining alone is not sufficient to confirm that mineralization in vitro represents bone formation. Calcif. Tissue Int. 2003, 72(5):537-547. May, Epub 2003 May 6.
2. Boot-Handford R.P., Michaelidis T.M., Hillarby M.C., Zambelli A., Denton J., Hoyland J.A., Freemont A.J., Grant M.E., Wallis G.A. The bcl-2 knockout mouse exhibits marked changes in osteoblast phenotype and collagen deposition in bone as well as a mild growth plate phenotype. Int. J. Exp. Pathol. 1998, 79(5):329-335. Oct.
3. Cheng A., Genever P.G. SOX9 determines RUNX2 transactivity by directing intracellular degradation. J. Bone Miner. Res. 2010, 25:2680-2689.
4. Cheung J.O., Grant M.E., Jones C.J., Hoyland J.A., Freemont A.J., Hillarby M.C. Apoptosis of terminal hypertrophic chondrocytes in an in vitro model of endochondral ossification. Pathology 2003, 201(3):496-503. Nov.
5. de Crombrugghe B., Lefebvre V., Nakashima K. Regulatory mechanisms in the pathways of cartilage and bone formation. Curr. Opin. Cell Biol. 2001, 13(6):721-727. Dec, Review.
6. Dietz S., Rother K., Bamberger C., Schmale H., Mössner J., Engeland K. Differential regulation of transcription and induction of programmed cell death by human p53-family members p63 and p73. FEBS Lett. 2002, 525(1-3):93-99. Aug 14.
7. Fernandez-Teran M., Ros M.A. The apical ectodermal ridge: morphological aspects and signaling pathways. Int. J. Dev. Biol. 2008, 52(7):857-871.
8. Finlan L.E., Hupp T.R. p63: the phantom of the tumor suppressor. Cell Cycle 2007, 6(9):1062-1071. May 2, Epub 2007 May 19.
9. Hinoi E., Bialek P., Chen Y.T., Rached M.T., Groner Y., Behringer R.R., Ornitz D.M., Karsenty G. Runx2 inhibits chondrocyte proliferation and hypertrophy through its expression in the perichondrium. Genes Dev. 2006, 20:2937-2942.
10. Ikegami D., Akiyama H., Suzuki A., Nakamura T., Nakano T., Yoshikawa H., Tsumaki N. Sox9 sustains chondrocyte survival and hypertrophy in part through Pik3ca-Akt pathways. Development 2011, 138:1507-1519.
11. Inada M., Yasui T., Nomura S., Miyake S., Deguchi K., Himeno M., Sato M., Yamagiwa H., Kimura T., Yasui N., Ochi T., Endo N., Kitamura Y., Kishimoto T., Komori T. Maturational disturbance of chondrocytes in Cbfa1-deficient mice. Dev. Dyn. 1999, 214:279-290.
12. Kim I.S., Otto F., Zabel B., Mundlos S. Regulation of chondrocyte differentiation by Cbfa1. Mech. Dev. 1999, 80(2):159-170. Feb.
13. Kim H.J., Minashima T., McCarthy E.F., Winkles J.A., Kirsch T. Progressive ankylosis protein (ANK) in osteoblasts and osteoclasts controls bone formation and bone remodeling. J. Bone Miner. Res. 2010, 25(8):1771-1783. Aug.
14. Komori T. Regulation of bone development and extracellular matrix protein genes by RUNX2. Cell Tissue Res. 2010, 339(1):189-195. Jan, Epub 2009 Aug 1. Review.
15. Lefebvre V., Garofalo S., de Crombrugghe B. Type X collagen gene expression in mouse chondrocytes immortalized by a temperature-sensitive simian virus 40 large tumor antigen. J Cell Biol. 1995, 128:239-245.
16. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
17. Mello M.A., Tufan A.C., Daumer K.M., Pucci B., Lafond T., Hall D.J., Tuan R.S. Regulation of chondrogenesis and cartilage maturation in vitro: role of TGF-β1, thyroid hormone, and Wnt signaling. The Growth Plate 2002, 37-52. IOS Press. I.M. Shapiro (Ed.).
18. Mills A.A. P63: oncogene or tumor suppressor?. Curr. Opin. Genet. Dev. 2006, 16:38-44.
19. Mills A.A., Zheng B., Wang X.J., Vogel H., Roop D.R., Bradley A. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 1999, 398(6729):708-713. Apr 22.
20. Ornitz D.M., Marie P.J. FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev. 2002, 16(12):1446-1465. Jun 15.
21. Oshima Y., Akiyama T., Hikita A., Iwasawa M., Nagase Y., Nakamura M., Wakeyama H., Kawamura N., Ikeda T., Chung U.I., Hennighausen L., Kawaguchi H., Nakamura K., Tanaka S. Pivotal role of Bcl-2 family proteins in the regulation of chondrocyte apoptosis. J. Biol. Chem. 2008, 283(39):26499-26508. Sep 26, Epub 2008 Jul 16.
22. Otto F., Thornell A.P., Crompton T., Denzel A., Gilmour K.C., Rosewell I.R., Stamp G.W., Beddington R.S., Mundlos S., Olsen B.R., Selby P.B., Owen M.J. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997, 89:765-771.
23. Ovchinnikov D. Alcian blue/alizarin red staining of cartilage and bone in mouse. Cold Spring Harb. Protoc. 2009, (3). pdb.prot5170.
24. Perez C.A., Pietenpol J.A. Transcriptional programs regulated by p63 in normal epithelium and tumors. Cell Cycle 2007, 6(3):246-254. Feb 1, Epub 2007 Feb 3. Review.
25. Petitjean A., Ruptier C., Tribollet V., Hautefeuille A., Chardon F., Cavard C., Puisieux A., Hainaut P., Caron de Fromentel C. Properties of the six isoforms of p63: p53-like regulation in response to genotoxic stress and cross talk with DeltaNp73. Carcinogenesis 2008, 29(2):273-281. Feb, Epub 2007 Nov 28.
26. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29:e45.
27. Romano R.A., Birkaya B., Sinha S. Defining the regulatory elements in the proximal promoter of DeltaNp63 in keratinocytes: potential roles for Sp1/Sp3, NF-Y, and p63. J. Invest. Dermatol. 2006, 126(7):1469-1479. Jul, Epub 2006 Apr 27.
28. Shapiro I.M., Adams C.S., Freeman T., Srinivas V. Fate of the hypertrophic chondrocyte: microenvironmental perspectives on apoptosis and survival in the epiphyseal growth plate. Birth Defects Res. C Embryo Today 2005, 75(4):330-339. Dec.
29. Takeda S., Bonnamy J.P., Owen M.J., Ducy P., Karsenty G. Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice. Genes Dev. 2001, 15:467-481.
30. Trink B., Osada M., Ratovitski E., Sidransky D. p63 transcriptional regulation of epithelial integrity and cancer. Cell Cycle 2007, 6(3):240-245. Feb 1, Epub 2007 Feb 3. Review.
31. van Bokhoven H., Hamel B.C., Bamshad M., Sangiorgi E., Gurrieri F., Duijf P.H., Vanmolkot K.R., van Beusekom E., van Beersum S.E., Celli J., Merkx G.F., Tenconi R., Fryns J.P., Verloes A., Newbury-Ecob R.A., Raas-Rotschild A., Majewski F., Beemer F.A., Janecke A., Chitayat D., Crisponi G., Kayserili H., Yates J.R., Neri G., Brunner H.G. p63 gene mutations in EEC syndrome, limb-mammary syndrome, and isolated split hand-split foot malformation suggest a genotype-phenotype correlation. Am. J. Hum. Genet. 2001, 69(3):481-492. Sep, Epub 2001 Jul 17.
32. Wu G., Nomoto S., Hoque M.O., Dracheva T., Osada M., Lee C.C., Dong S.M., Guo Z., Benoit N., Cohen Y., Rechthand P., Califano J., Moon C.S., Ratovitski E., Jen J., Sidransky D., Trink B. DeltaNp63alpha and TAp63alpha regulate transcription of genes with distinct biological functions in cancer and development. Cancer Res. 2003, 63(10):2351-2357. May 15.
33. Wu G., Osada M., Guo Z., Fomenkov A., Begum S., Zhao M., Upadhyay S., Xing M., Wu F., Moon C., Westra W.H., Koch W.M., Mantovani R., Califano J.A., Ratovitski E., Sidransky D., Trink B. DeltaNp63alpha up-regulates the Hsp70 gene in human cancer. Cancer Res. 2005, 65(3):758-766. Feb 1.
34. Yadav M.C., Simão A.M., Narisawa S., Huesa C., McKee M.D., Farquharson C., Millán J.L. Loss of skeletal mineralization by the simultaneous ablation of PHOSPHO1 and alkaline phosphatase function: a unified model of the mechanisms of initiation of skeletal calcification. J. Bone Miner. Res. 2011, 26(2):286-297. Feb. 10.1002/jbmr.195. Epub 2010 Aug 3.
35. Yang A., Schweitzer R., Sun D., Kaghad M., Walker N., Bronson R.T., Tabin C., Sharpe A., Caput D., Crum C., McKeon F. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 1999, 398(6729):714-718. Apr 22.
36. Zheng Q., Zhou G., Morello R., Chen Y., Garcia-Rojas X., Lee B. Type X collagen gene regulation by Runx2 contributes directly to its hypertrophic chondrocyte-specific expression in vivo. J. Cell Biol. 2003, 162(5):833-842. Sep 1.
37. Zheng Q., Keller B., Zhou G., Napierala D., Chen Y., Zabel B., Parker A., Lee B. Localization of the cis-enhancer element for mouse type X collagen expression in hypertrophic chondrocytes in vivo. J. Bone Miner. Res. 2009, 24:1022-1032.
38. Zhou G., Zheng Q., Engin F., Munivez E., Chen Y., Sebald E., Krakow D., Lee B. Dominance of SOX9 function over RUNX2 during skeletogenesis. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:19004-19009.